Biopharma Daily Stock Updates - 01/21/21

$XBI $150.78 (-2.17%) 📉


COVID:

$VBIV (-6.53%) - VBI Vaccines Announces Progress of Coronavirus Vaccine Program

https://mail.google.com/mail/u/2/#inbox/FMfcgxwKkbldSnQJJCGqTmjpbtSTLWxK


$MRNA (+6.26%) - Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by Takeda

https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participant-dosed-phase-12-study-moderna


PIPELINE:

$INMB (-18.95%) - INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial

https://inmunebio.com/index.php/en/news-2/2021/446-muneioncnnouncesro1595oundtoecreaseeuro20210121


$AMRN (+1.77%) - ICOSAPENT ETHYL INCLUDED IN THE CHINESE SOCIETY OF CARDIOLOGY (CSC) UPDATED GUIDELINES FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES

https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-included-chinese-society-cardiology-csc-updated


$ORMP (+6.26%) - Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin Study

https://oramed.gcs-web.com/news-releases/news-release-details/oramed-doses-patients-across-multiple-sites-phase-3-oral-insulin


$CDAK (-5.41%) - Codiak’s Versatile engEx™ Platform for Engineered Exosomes Published in the Journal Molecular Therapy

https://ir.codiakbio.com/news-releases/news-release-details/codiaks-versatile-engextm-platform-engineered-exosomes-published


$HTRX (+0.11%) - Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery

https://herontherapeutics.gcs-web.com/news-releases/news-release-details/heron-therapeutics-announces-publication-results-epoch-1-follow


$SPRO (+3.14%) - Spero Therapeutics Announces Issuance of Allowance for a U.S. Patent Covering Lead Candidate Tebipenem HBr

https://investors.sperotherapeutics.com/news-releases/news-release-details/spero-therapeutics-announces-issuance-allowance-us-patent


FINANCIAL:

$EDIT (-11.11%) - Pricing of an underwritten offering of 3,500,000 shares of its common stock at a public offering price of $66.00 per share

https://ir.editasmedicine.com/news-releases/news-release-details/editas-medicine-announces-pricing-offering-common-stock-0


$PGEN (-2.87%) - Precigen Announces Proposed Public Offering of Common Stock

https://investors.precigen.com/news-releases/news-release-details/precigen-announces-proposed-public-offering-common-stock


$MRUS (+8.75%) - Pricing of an underwritten public offering of 4,848,485 common shares at a public offering price of $24.75 per share.

https://ir.merus.nl/news-releases/news-release-details/merus-announces-pricing-public-offering-common-shares-0


$ONCS (+23.09%) - Pricing of an underwritten public offering of 7,711,284 shares of its common stock at a price of $5.45 per share

https://ir.oncosec.com/press-releases/detail/2075/oncosec-medical-announces-pricing-of-42-0-million-public


0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE